“I met Arijit back in 2012 when he was a postdoc in the lab where I was doing my graduate studies – he was recruited for his expertise in phage display and structural biology, which he introduced to the lab. In just the time he worked at Sinai, he used phage display to identify peptides, synthesized peptides and tested them in ELISA for binding, used docking/modeling to identify epitopes, and used flow cytometry to show CD69 binding peptides. Arijit is extremely knowledgeable and skilled in these areas and he's great to work with – he's collaborative, easy going and insightful. Even though we only worked together for 8 months, he's someone I often call on when thinking about new business and scientific ideas. It's been an absolute pleasure to continue our professional relationship since we worked together in the lab. ”
Arijit Bhowmick, Ph.D.
New York City Metropolitan Area
2K followers
500+ connections
About
Currently leading Insitro's oligo therapy drug discovery efforts across targets…
Activity
-
Just when we thought we could hold on to those last fading rays of summer sun ☀️, reality knocks on our door with the familiar sounds of alarm…
Just when we thought we could hold on to those last fading rays of summer sun ☀️, reality knocks on our door with the familiar sounds of alarm…
Liked by Arijit Bhowmick, Ph.D.
-
Interested in the role of AI in the future of science and medicine? Check this out — hopefully you’ll enjoy the conversation as much as we did! :)
Interested in the role of AI in the future of science and medicine? Check this out — hopefully you’ll enjoy the conversation as much as we did! :)
Liked by Arijit Bhowmick, Ph.D.
-
Get ready audio blog listeners! We’re excited to announce our debut of The Nucleus, which will be released on August 29. Join us as our first host…
Get ready audio blog listeners! We’re excited to announce our debut of The Nucleus, which will be released on August 29. Join us as our first host…
Liked by Arijit Bhowmick, Ph.D.
Experience
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Education
-
-
-
Antibody, immunology, structural biology, with a lot of rock n roll and drumming as the founder member of a rock band
-
-
Courses : Biochemistry, Molecular biology, Virology, Toxicology, Biophysics, Genetics, Immunology, Bio-statistics
-
-
Courses : Chemistry, Zoology, Bio-technology
-
Publications
-
Chemically Modified RNA Aptamers and Uses Thereof (2016)
USPTO, WO/2018/075264
Patent: A platform technology for the selection and development of highly stable, high affinity, modified RNA aptamers for therapeutic, diagnostic and research use
Other authors -
Honors & Awards
-
ELabNYC
ELabNYC
Selected among the top 20 technologies in NY/NJ area from over 250 applications, to participate in the prestigious competitive Bio and Health Tech accelerator program in NYC, designed to help scientists, engineers and doctors working with technology based innovations, to form new ventures in the life science and healthcare technology space.
Languages
-
English
Full professional proficiency
-
Hindi
Full professional proficiency
-
Bengali
Native or bilingual proficiency
Recommendations received
4 people have recommended Arijit
Join now to viewMore activity by Arijit
-
Check out part 2 of our CMO David Dimmock interview with CGTLive about our work using AI to engineer an antisense oligonucleotide (ASO) therapeutic…
Check out part 2 of our CMO David Dimmock interview with CGTLive about our work using AI to engineer an antisense oligonucleotide (ASO) therapeutic…
Liked by Arijit Bhowmick, Ph.D.
-
Our CMO, David Dimmock, spoke with CGTLive about our work using AI to engineer an antisense oligonucleotide (ASO) therapeutic. We engineered an…
Our CMO, David Dimmock, spoke with CGTLive about our work using AI to engineer an antisense oligonucleotide (ASO) therapeutic. We engineered an…
Liked by Arijit Bhowmick, Ph.D.
-
I am absolutely thrilled to announce that the course I've been working on for the past 18 months called "mRNA as Medicines" is now available to the…
I am absolutely thrilled to announce that the course I've been working on for the past 18 months called "mRNA as Medicines" is now available to the…
Liked by Arijit Bhowmick, Ph.D.
-
We're thrilled to announce that our CEO, Christopher Hart, has shared valuable insights on unlocking the potential of oligonucleotide-based medicines…
We're thrilled to announce that our CEO, Christopher Hart, has shared valuable insights on unlocking the potential of oligonucleotide-based medicines…
Liked by Arijit Bhowmick, Ph.D.
Other similar profiles
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore More